SCHEMBL17834855

SCHEMBL17834855

CCC[C@H]1CC[C@H](c2ccc(-c3cnc(-c4ccc(C[C@H](NC(=O)c5ccc(C(C)(C)C)s5)C(=O)O)cc4)nc3)cc2)CC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 1/20 0.41
▸ LMNA P02545 1/20 0.41
▸ MAPT P10636 1/20 0.41
▸ KIFC1 Q9BW19 2/20 0.39
▸ CYP2C9 P11712 1/20 0.39
▸ DGAT1 O75907 1/20 0.36
▸ ITGB3 P05106 6/20 0.36
▸ ITGA2B P08514 6/20 0.36
▸ MME P08473 4/20 0.35
▸ ITGB1 P05556 4/20 0.35
▸ ACE P12821 2/20 0.35
▸ ACE2 Q9BYF1 2/20 0.35
▸ ITGA4 P13612 1/20 0.35
▸ ITGB7 P26010 1/20 0.35
▸ ITGA5 P08648 3/20 0.35
▸ ITGAV P06756 2/20 0.35
▸ ITGB5 P18084 2/20 0.35
▸ CPA1 P15085 1/20 0.35
▸ MEN1 O00255 1/20 0.34
▸ MAPK1 P28482 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17825449 0.95 KIFC1 (0.38) ALDH1A1LMNAMAPTKIFC1DGAT1
SCHEMBL17825448 0.95 KIFC1 (0.38) ALDH1A1LMNAMAPTKIFC1DGAT1
SCHEMBL17825447 0.95 KIFC1 (0.38) ALDH1A1LMNAMAPTKIFC1DGAT1
SCHEMBL17834920 0.95 KIFC1 (0.38) ALDH1A1LMNAMAPTKIFC1DGAT1
SCHEMBL17834538 0.93 ALDH1A1 (0.38) ALDH1A1LMNAMAPTKIFC1CYP2C9
SCHEMBL17834621 0.91 KIFC1 (0.37) KIFC1DGAT1ITGB3ITGA2BMME
SCHEMBL17834675 0.91 KIFC1 (0.37) KIFC1DGAT1ITGB3ITGA2BMME
SCHEMBL17834483 0.91 ACE (0.40) KIFC1MMEITGB1ACEACE2
SCHEMBL17834467 0.90 ALDH1A1 (0.37) ALDH1A1LMNAMAPTKIFC1CYP2C9
SCHEMBL17968905 0.90 ALDH1A1 (0.37) ALDH1A1LMNAMAPTKIFC1CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3230276-B1 GLP-1 RECEPTOR MODULATORS CELGENE INT II SARL (CH) 2020-09-02 — — EP disclosed
US-10034886-B2 GLP-1 receptor modulators CELGENE INTERNATIONAL II SÀRL (CH) 2018-07-31 — — US disclosed
US-10034886-B2 GLP-1 receptor modulators CELGENE INTERNATIONAL II SÀRL (CH) 2018-07-31 — — US disclosed
US-20180021346-A1 NOVEL GLP-1 RECEPTOR MODULATORS RECEPTOS LLC 2018-01-25 — — US disclosed
US-9795613-B2 GLP-1 receptor modulators CELGENE INTERNATIONAL II SÀRL (CH) 2017-10-24 — — US disclosed
US-9795613-B2 GLP-1 receptor modulators CELGENE INTERNATIONAL II SÀRL (CH) 2017-10-24 — — US disclosed
US-20160228450-A1 NOVEL GLP-1 RECEPTOR MODULATORS RECEPTOS LLC 2016-08-11 — — US disclosed
WO-2016094729-A1 GLP-1 RECEPTOR MODULATORS CELGENE INTERNATIONAL II SARL (CH) 2016-06-16 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160228450-A1 NOVEL GLP-1 RECEPTOR MODULATORS GLP1R, GIPR, NPY1R ALDH1A1 4770/4885LMNA 2192/4885MAPT 4366/4885
US-20180021346-A1 NOVEL GLP-1 RECEPTOR MODULATORS GLP1R, GIPR, NPY1R ALDH1A1 4770/4885LMNA 2192/4885MAPT 4366/4885
US-10034886-B2 GLP-1 receptor modulators GLP1R, GIPR, GCGR ALDH1A1 4737/4885LMNA 1558/4885MAPT 4208/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback